Abatacept in Psoriasis and Psoriatic Arthritis: a single centre, placebo-controlled, crossover study.
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2018
At a glance
- Drugs Abatacept (Primary)
- Indications Psoriatic arthritis
- Focus Pharmacodynamics
- Sponsors Bristol-Myers Squibb
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism
- 26 Feb 2017 Status changed from recruiting to completed.
- 13 Jun 2015 Results assessing CD4 positive T-cell expression presented at the 16th Annual Congress of the European League Against Rheumatism.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History